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The phosphazenium salts (protic ionic liquids, PILs/protic molten salts, PMOSs) (6a-6d and 7a) of the free phosphazene 
bases (4a-4d and 5a) have been prepared by the reactions of the corresponding cyclotriphosphazenes with the bulky gentisic 
acid. The structures of the PMOS have been evaluated using the elemental analyses, FTIR, 1H, 13C{1H} and 31P{1H} NMR 
data. The molecular and crystal structures of 4a and 6c are established by X-ray crystallography. The thermal properties of 
the PMOS are determined using TG and DTA techniques. On the other hand, the antimicrobial activities of the free 
phosphazene bases (4a-4d and 5a-5d) and PMOSs (6a-6d and 7a) are screened against the selected bacteria and yeast 
strains. The antimicrobial activities of the free phosphazene bases and the PMOSs are compared. The interactions of the 
phosphazenes and their salts with plasmid DNA are elucidated by the agarose gel electrophoresis. The evaluations of the 
cytotoxic activities of these compounds are also studied against to L929 fibroblast and breast cancer cells (MDA-MB-231).  
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Hexachlorocyclotriphosphazene, N3P3Cl6 (1) has six 
very reactive P-Cl bonds, and it is a well-known 
starting compound for preparation of numerous 
trimeric and polymeric organophosphazene 
derivatives.1,2 The replacement reactions of N3P3Cl6 
with a large number of mono-, di-, tri- and tetradentate 
reagents led to the formation of the partly and/or fully 
substituted trimeric phosphazene derivatives.3-8 The 
pendant armed monospirocyclotriphosphazene 
derivatives are very rare,9,10 and they have four reactive 
P-Cl bonds available for the syntheses of tetra-
substituted organophosphazenes.11,12 A number of 
organocyclotriphosphazenes are used to liquid 
crystals,13,14 ionic liquids,15,16 organic light emitting 
diodes (OLEDs),17,18 Li-ion batteries,19 fluorescence 
sensors20 and biomaterials.21 The cyclophosphazenes 
are also used as antimicrobial agents against some 
bacteria and yeast strains,22,23 and as anticancer agents 
against various cancer cell lines.24,25 
The fully amino and alkylamino substituted 
cyclotriphosphazenes ought to be used as the potential 
phosphazene bases. The values of pKa′ of some 
organocyclotriphosphazenes were presented in the 
literature.26 The strong phosphazene bases can form 
stable monoprotonated salts with inorganic and 
organic acids such as HCl, HF, HClO4 and 
CH3COOH.27 In recent years, several papers have 
been published about the pendant armed 
phosphazenium salts with bulky organic acids. These 
salts may occur by proton transfer from Brønsted acid 
to Brønsted base (for instance; free phosphazene 
base), and they can be termed as protic molten salts 
(PMOSs).28-31 These salts can also be defined as protic 
ionic liquids (PILs) at the same time. Phosphazenium 
salts (PMOSs or PILs) are soluble in various organic 
apolar/polar solvents and dissoluble slightly in water. 
Since, in biological studies the solubilities in the 
biological fluids are so crucial, the investigation of 
antimicrobial and cytotoxic activities of the PMOSs 
may be quite important and useful for future studies. 
However, the antibacterial, antifungal28-31 and 
anticancer activity30,31 studies of phosphazenium salts 
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are also very rare. Furthermore, thermal analysis 
studies are used to determine the thermal properties of 
the cyclotriphosphazenes and their salts, 
PMOSs/PILs.29-31 The data obtained from these 
measurements may be useful to determine whether 
PMOSs are likely to be used as ionic liquids.  
In the last two decades, several chiral 
cyclophosphazene derivatives were synthesized and 
the chiralities of these products were investigated 
using X-ray crystallography, HPLC and/or 31P NMR 
spectroscopy on the addition of (R)-(+)-2,2,2-
trifluoro-1-(9’-anthryl)-ethanol (CSA).32-34 However, 
there is no study published in the literature about the 
determination of the chiral properties of the 
phosphazenium salts by X-ray crystallography. In this 
study, the protic molten salts (PMOSs; 6a-6d and 7a) 
were prepared from the reactions of the fully 
substituted phosphazene bases (4a-4d and 5a) with 
the gentisic acid for the assessment of their structural, 
stereogenic and thermal properties, and antibacterial, 
antifungal and cytotoxic activities. 
 
Materials and Methods 
 
Reagents  
The solvents and reagents were purified and  
dried using conventional methods before use.  
N3P3Cl6 (Aldrich), pyridine-2-carboxaldehyde (Merck), 
N-methylpropane-1,3-diamine (Merck), 3-amino-1-
propanol (Merck), pyrrolidine (Fluka), piperidine 
(Fluka), morpholine (Fluka), DASD (Fluka) and  
2,5-dihydroxybenzoic acid (Merck) were supplied. 
The free phosphazene bases (4a-4d and 5a-5d) were 
prepared according to reported procedures.35,36 
 
Measurements 
The Cl exchange reactions were carried out under 
Ar atmosphere, and they were followed by thin-layer 
chromatography (TLC) on Merck DC Alufolien 
Kiesegel 60 B254 sheets. The column chromatography 
was performed on Merck Kiesegel 60 (230–400 mesh 
ATSM) silica gel. The melting points of the 
compounds were determined with a Gallenkamp 
apparatus using a capillary tube. Electron spray 
ionization-mass spectrum (ESI-MS) of 5a was 
detected on the AGILENT 1100 MSD mass 
spectrometer. The Fourier transform infrared (FTIR) 
spectra were recorded on a Jasco FT/IR-430 
spectrometer in KBr discs and reported in cm-1 units. 
1H, 13C, and 31P NMR spectra were monitored on a 
Bruker DPX FT-NMR (500 MHz) spectrometer 
(SiMe4 as internal and 85% H3PO4 as external 
standards), operating at 400.13, 100.62 and 242.93 
MHz. The NMR spectrometer was equipped with a  
5 mm PABBO BB inverse gradient probe and standard 
Bruker pulse programs37 were used. Microanalyses 
were realized by the microanalytical service of 
Ankara University. Thermal stabilities and 
decomposition features of the PMOS were evaluated 
using thermogravimetric (TG)-differential thermal 
analysis (DTA). TG and DTA curves were scanned by 
a PYRIS Diamond TG/DTA apparatus in N2 
(platinum crucibles, heating rate: 10 °C/min, mass 
~10 mg and temperature range 35-1150 °C). 
 
Single crystal X-ray structure determinations 
The colorless crystals of 4a and 6c were 
crystallized from toluene at ambient temperature. The 
crystallographic details of these compounds were 
listed in Table 1. Crystallographic data of 4a and 6c 
were recorded on a Bruker Kappa APEXII CCD  
area-detector diffractometer using Mo K radiation  
( = 0.71073 Å) at T = 120(2) K. Absorption 
correction by multi-scan38 was applied. The structures 
were solved by direct methods and refined by  
full-matrix least squares against F2 using all data.39,40 
All non-H atoms were refined anisotropically. The 
molecular and packing diagrams together with the 
 
Table 1 ― Crystallographic Details for 4a and 6c 
 4a 6c 
Empirical Formula C29H52N9OP3 C32H50N9O9P3 
Fw 635.71 797.72 
Crystal System triclinic triclinic 
Space Group P -1 P -1 
a (Å) 9.4852(3) 11.0344(3) 
b (Å) 10.2984(3) 11.8558(3) 
c (Å) 17.641(4) 15.9041(4) 
 () 81.895(3) 72.367(3) 
 () 89.865(4) 88.550(4) 
 () 77.058(3) 72.352(3) 
V ( 3) 1661.9(4) 1884.45(8) 
Z 2 2 
 (cm−1) 0.71073 (Mo K) 0.71073 (Mo K) 
 (calcd) (g cm−3) 1.270 1.406 
Number of Reflections 
Total 5843 
 
6642 
Number of Reflections 
Unique 5207 
 
4600 
Rint 0.0488 0.0691 
2max () 50.06 50.06 
Number of Parameters 379 482 
R [F2 >2(F2)] 0.0640 0.0831 
wR 0.1387 0.1279 
 
o
A
ELMAS et al.: PHOSPHORUS-NITROGEN COMPOUNDS 
 
 
535
ring conformations were drawn by the ORTEP-3 
program incorporated into the WinGX package. The 
C-bonded H atoms were positioned geometrically at 
distances of 0.93 Å (CH) and 0.97 Å (CH2) from the 
parent C atoms; a riding model was used during the 
refinement process and the Uiso(H) values were 
constrained to be 1.2Ueq(carrier atom). 
 
General procedure for the syntheses of the free phosphazene 
base (5a) and PMOSs (6a-6d and 7a) 
 
Synthesis of 2-pyridyl(N/N)spirotetrapiperidino-
cyclotriphosphazene (5a) 
N-(2-Pyridyl)-methyl-N'-methylpropane-1,3-diamine 
(3) was synthesized from the reactions of pyridine-2-
carboxyaldehyde with N-methylpropane-1,3-diamine 
in ethanol at −10 °C, as described in the literature.41 
The Cl substitution reaction of N3P3Cl6 with 3  
gave the partly substituted 2-pyridyl(N/N) 
spirocyclotriphosphazene (5) (with a yield of 57%) in 
dry THF according to the published paper.35 A 
solution of 5 (0.80 g, 1.80 mmol) and triethylamine 
(1.00 mL, 7.20 mmol) in dry THF (100 mL) was 
added slowly to a solution of piperidine (1.42 mL, 
14.40 mmol) in dry THF (50 mL) under Ar 
atmosphere. The mixture was stirred for 2 days at 
ambient temperature, and then it was refluxed for  
3 days. The crude product was purified by column 
chromatography using toluene-THF (3:1) as eluent. A 
colorless powder of 5a was crystallized from toluene. 
Yield: 0.74 g (63%). M.P.: 155 °C. Anal. Calcd. for 
P3N10C30H55 . 0.5 C7H8, 694.40 g/mol: C, 57.98;  
H, 8.57; N, 20.18. Found: C, 57.64; H, 8.28; N, 20.02. 
ESI-MS (Ir %): m/z 649 ([M+H]+, 100). FTIR  
(KBr, cm−1): ν 2962, 2848 (C-H aliph.), 1253 
(asymm.), 1151 (symm.) (P=N). 1H NMR (400 MHz, 
CDCl3, ppm, in Scheme 1 the numberings of protons 
were given): δ 8.48 (d, H, 3JHH=4.4 Hz, H5), 7.72  
(d, H, 3JHH=7.2 Hz, H2), 7.63 (dd, H, 3JHH=7.2 Hz, 
3JHH=7.6 Hz, H3), 7.11 (dd, H, 3JHH=6.2 Hz, 3JHH=6.2 
Hz, H4), 4.11 (d, 2H, 3JPH=7.2 Hz, Py-CH2-N), 3.16 
(m, 2H, CH3-N-CH2), 3.01 (m, 2H, Py-CH2-N-CH2), 
3.06 [m, 8H, N-CH2 (piper)], 2.98 [m, 8H, N-CH2 
(piper)], 2.57 (d, 3H, 3JPH=13.2 Hz, N-CH3), 1.80  
(m, 2H, N-CH2-CH2), 1.48 [m, 16H, N-CH2-CH2 
(piper)], 1.31 [m, 4H, N-CH2-CH2-CH2 (piper)],  
1.28 [m, 4H, N-CH2-CH2-CH2 (piper)]. 13C NMR  
(100 MHz, CDCl3, ppm, in Scheme 1 the numberings 
of carbons were given): δ 160.92 (d, 3JPC=12.3 Hz, C1), 
148.57 (s, C5), 136.41 (s, C3), 121.95 (s, C2), 121.62  
(s, C4), 53.03 (m, Py-CH2-N), 51.00 (s, Py-CH2-N-CH2), 
47.32 (s, CH3-N-CH2), 45.54 and 45.42 [s, N-CH2 
(piper)], 36.54 (m, N-CH3), 25.50 (s, N-CH2-CH2), 
26.46 and 26.31 [(s, N-CH2-CH2 (piper)], 25.10 and 
24.97 [(s, N-CH2-CH2-CH2 (piper)].  
 
 
Scheme 1 ― Cyclotriphosphazene derivatives are synthesized from the reactions of 2-pyridylspiro(N/O)cyclotriphosphazene with 
secondary amines and their phosphazenium salts. 
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Synthesis of 2-pyridyl(N/O)spirotetrapiperidino-PMOS (6a) 
A solution of 4a (0.50 g, 0.79 mmol) in dry THF 
(30 mL) was slowly added by the dropwise to gentisic 
acid (0.12 g, 0.79 mmol) in dry THF (10 mL) at the 
ambient temperature. The reaction mixture was 
refluxed for over 45 h. After that, the solvent was 
evaporated under vacuo. A colourless powder of 6a 
was crystallized from toluene. Yield: 0.48 g (77%). 
M.P.: 105 °C. Anal. Calcd. for P3N9O5C36H57 . C7H8, 
880.40 g/mol: C, 58.66; H, 7.44; N, 14.33. Found:  
C, 58.34; H, 7.19; N, 14.16. FTIR (KBr, cm−1):  
ν 3195 (O-H), 2919, 2849 (C-H aliph.), 2664 (N+-H), 
1572 (asymm.), 1374 (symm.) (COO−), 1240 (asymm.), 
1194 (symm.) (P=N). 1H NMR (400 MHz, CDCl3, 
ppm, in Scheme 1 the numberings of protons were 
given): δ 9.12 (b, 2H, Ar-OH), 8.54 (d, H, 3JHH=4.0 
Hz, H5), 7.73 (dd, H, 3JHH=8.0 Hz, 3JHH=7.6 Hz, H3), 
7.66 (d, H, 3JHH=7.6 Hz, H2), 7.55 (d, 1H, 3JHH=2.8 
Hz, Hb), 7.14 (dd, H, 3JHH=7.6 Hz, 3JHH=7.6 Hz, H4), 
6.90 (dd, 1H, 3JHH=8.8 Hz, 3JHH=3.2 Hz, Hd), 6.73 (d, 
1H, 3JHH=8.4 Hz, He), 4.51 (t, H, 3JPH=10.8 Hz, 
2JHH=5.2 Hz, O-CH2), 4.47 (t, H, 3JPH=10.4 Hz, 
2JHH=5.2 Hz, O-CH2), 4.28 (d, 2H, 3JPH=9.2 Hz,  
Py-CH2-N), 3.26 (t, H, 3JPH=11.6 Hz, 2JHH=4.8 Hz, 
Py-CH2-N-CH2), 3.20 (t, H, 3JPH=11.6 Hz, 2JHH=5.2 Hz, 
Py-CH2-N-CH2), 3.07 [m, 8H, N-CH2 (piper)], 3.01 
[m, 8H, N-CH2 (piper)], 1.93 (m, 2H, 3JHH=4.4 Hz, 
3JHH=5.6 Hz, N-CH2-CH2), 1.51 [m, 8H, N-CH2-CH2 
(piper)], 1.44 [m, 8H, N-CH2-CH2 (piper)], 1.42 [m, 
4H, N-CH2-CH2-CH2 (piper)], 1.37 [m, 4H,  
N-CH2-CH2-CH2 (piper)]. 13C NMR (100 MHz, CDCl3, 
ppm, in Scheme 1 the numberings of carbons were 
given): δ 173.29 (s, COO−), 157.65 (d, 3JPC=10.0 Hz, C1), 
154.91 (s, Cf), 148.63 (s, C5), 148.35 (s, Cc), 137.80 
(s, C3), 122.67 (s, Ca), 122.07 (s, C2), 121.75 (s, C4), 
117.07 (s, Cd), 116.95 (s, Cb), 116.25 (s, Ce), 67.80 (d, 
2JPC=7.7 Hz, O-CH2), 52.51 (d, 2JPC=2.0 Hz, Py-CH2-
N), 47.06 (s, Py-CH2-N-CH2), 45.40 and 45.36 [s, N-
CH2 (piper)], 25.97 and 25.93 [(s, N-CH2-CH2 
(piper)], 25.53 (s, N-CH2-CH2), 24.58 and 24.34 [(s, 
N-CH2-CH2-CH2 (piper)]. 
 
Synthesis of 2-pyridyl(N/O)spirotetrapyrrolidino-PMOS (6b) 
The work-up procedure was similar to that of 
compound 6a, using 4b (0.50 g, 0.86 mmol) and 
gentisic acid (0.13 g, 0.86 mmol). The reaction 
mixture was refluxed for over 45 h. After that, the 
solvent was evaporated under vacuo. A colourless 
powder of 6b was crystallized from toluene.  
Yield: 0.46 g (73%). Anal. Calcd. for P3N9O5C32H49, 
732.31 g/mol: C, 52.49; H, 6.74; N, 17.21. Found: C, 51.99; 
H, 6.85; N, 16.96. FTIR (KBr, cm−1): ν 2967, 2870 
(C-H aliph.), 2642 (N+-H), 1571 (asymm.), 1374 
(symm.) (COO-), 1236 (asymm.), 1198 (symm.) 
(P=N). 1H NMR (400 MHz, CDCl3, ppm, in Scheme 
1 the numberings of protons were given): δ 8.51 (d, 
H, 3JHH=4.8 Hz, H5), 7.71 (dd, H, 3JHH=8.4 Hz, 
3JHH=7.2 Hz, H3), 7.65 (d, H, 3JHH=7.2 Hz, H2), 7.58 
(d, 1H, 3JHH=3.2 Hz, Hb), 7.17 (dd, H, 3JHH=7.2 Hz, 
3JHH=7.6 Hz, H4), 6.87 (dd, 1H, 3JHH=9.2 Hz, 3JHH=3.2 
Hz, Hd), 6.70 (d, 1H, 3JHH=8.4 Hz, He), 4.46 (t, H, 
3JPH=11.6 Hz, 2JHH=4.8 Hz, O-CH2), 4.42 (t, H, 
3JPH=10.8 Hz, 2JHH=4.8 Hz, O-CH2), 4.22 (d, 2H, 
3JPH=8.8 Hz, Py-CH2-N), 3.10 (m, H, Py-CH2-N-
CH2), 3.20 [m, 8H, N-CH2 (pyrr)], 3.15 [m, 8H, N-
CH2 (pyrr)], 1.92 (m, 2H, 3JHH=5.2 Hz, 3JHH=5.2 Hz, 
N-CH2-CH2), 1.79 [m, 8H, N-CH2-CH2 (pyrr)], 1.70 
[m, 8H, N-CH2-CH2 (pyrr)]. 13C NMR (100 MHz, 
CDCl3, ppm, in Scheme 1 the numberings of carbons 
were given): δ 173.45 (s, COO−), 158.03 (d, 3JPC=9.3 
Hz, C1), 154.73 (s, Cf), 148.66 (s, C5), 148.60 (s, Cc), 
137.27 (s, C3), 122.41 (s, Ca), 122.01 (s, C2), 121.03 
(s, C4), 118.24 (s, Cd), 116.53 (s, Cb), 116.49 (s, Ce), 
67.36 (d, 2JPC=6.1 Hz, O-CH2), 53.08 (s, Py-CH2-N), 
46.94 (s, Py-CH2-N-CH2), 46.43 and 46.29 [s, N-CH2 
(pyrr)], 26.35 [(d, 3JPC=9.3 Hz, N-CH2-CH2 (pyrr)], 
26.24 [(d, 3JPC=9.2 Hz, N-CH2-CH2 (pyrr)], 26.19 (s, 
N-CH2-CH2). 
 
Synthesis of 2-pyridyl(N/O)spirotetramorpholino-PMOS (6c) 
The work-up procedure was similar to that of 
compound 6a, using 4c (0.50 g, 0.78 mmol) and 
gentisic acid (0.12 g, 0.78 mmol). The reaction 
mixture was refluxed for over 45 h. After that, the 
solvent was evaporated under vacuo. A colourless 
powder of 6c was crystallized from toluene. Yield: 
0.42 g (68%). M.P.: 139 °C. Anal. Calcd. for 
P3N9O9C32H49, 796.29 g/mol: C, 48.27; H, 6.20; N, 
15.83. Found: C, 48.80; H, 6.36; N, 15.87. FTIR 
(KBr, cm−1): ν 2955, 2843 (C-H aliph.), 2675 (N+-H), 
1595 (asymm.), 1367 (symm.) (COO−), 1254 (asymm.), 
1188 (symm.) (P=N). 1H NMR (400 MHz, CDCl3, ppm, 
in Scheme 1 the numberings of protons were given):  
δ 8.75 (d, H, 3JHH=4.8 Hz, H5), 7.81 (dd, H,  
3JHH=8.0 Hz, 3JHH=7.2 Hz, H3), 7.75 (d, H,  
3JHH=8.0 Hz, H2), 7.41 (d, 1H, 3JHH=3.2 Hz, Hb), 7.32 
(dd, H, 3JHH=7.2 Hz, 3JHH=6.8 Hz, H4), 6.98 (dd, 1H, 
3JHH=8.4 Hz, 3JHH=2.8 Hz, Hd), 6.83 (d, 1H,  
3JHH=8.8 Hz, He), 4.41 (t, H, 3JPH=10.6 Hz, 2JHH=5.8 Hz, 
O-CH2), 4.38 (t, H, 3JPH=10.4 Hz, 2JHH=6.0 Hz, O-CH2), 
4.17 (d, 2H, 3JPH=8.8 Hz, Py-CH2-N), 3.64 [m, 8H,  
O-CH2 (morp)], 3.56 [m, 8H, O-CH2 (morp)], 3.12 (m, 
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H, Py-CH2-N-CH2), 3.08 [m, 16H, N-CH2 (morp)], 
1.95 (m, 2H, 3JHH=4.8 Hz, 3JHH=5.6 Hz, N-CH2-CH2). 
13C NMR (100 MHz, CDCl3, ppm, in Scheme 1 the 
numberings of carbons were given): δ 172.90  
(s, COO−), 157.66 (d, 3JPC=11.6 Hz, C1), 155.64 (s, Cf), 
148.79 (s, C5), 147.58 (s, Cc), 138.69 (s, C3), 123.56 
(s, Ca), 122.97 (s, C2), 121.96 (s, C4), 118.10 (s, Cd), 
114.69 (s, Cb), 113.26 (s, Ce), 67.12 [(s, O-CH2 
(morp)], 67.09 [(s, O-CH2 (morp)], 66.92 (d, 2JPC=7.6 
Hz, O-CH2), 52.21 (s, Py-CH2-N), 47.48 (s, Py-CH2-
N-CH2), 44.66 and 44.60 [s, N-CH2 (morp)], 26.66  
(s, N-CH2-CH2). 
 
Synthesis of 2-pyridyl(N/O)spirotetraDASD-PMOS (6d) 
The work-up procedure was similar to that of 
compound 6a, using 4d (0.50 g, 0.58 mmol) and 
gentisic acid (0.09 g, 0.58 mmol). The reaction 
mixture was refluxed for over 45 h. After that, the 
solvent was evaporated under vacuo. A colourless 
powder of 6d was crystallized from toluene. Yield: 
0.46 g (77%). M.P.: 119 °C. Anal. Calcd. for 
P3N9O13C44H65 . C7H8, 1112.42 g/mol: C, 55.07; H, 
6.61; N, 11.33. Found: C, 54.71; H, 6.35; N, 10.99. 
FTIR (KBr, cm−1): ν 2956, 2852 (C-H aliph.), 2668 
(N+-H), 1593 (asymm.), 1379 (symm.) (COO−), 1258 
(asymm.), 1196 (symm.) (P=N). 1H NMR (400 MHz, 
CDCl3, ppm, in Scheme 1 the numberings of protons 
were given): δ 8.57 (d, H, 3JHH=4.4 Hz, H5), 7.72  
(dd, H, 3JHH=7.6 Hz, 3JHH=7.6 Hz, H3), 7.66 (d, H, 
3JHH=7.6 Hz, H2), 7.42 (d, 1H, 3JHH=3.2 Hz, Hb), 7.14 
(dd, H, 3JHH=7.6 Hz, 3JHH=7.2 Hz, H4), 6.93 (dd, 1H, 
3JHH=8.2 Hz, 3JHH=3.2 Hz, Hd), 6.76 (d, 1H, 3JHH=8.8 
Hz, He), 4.45 (t, H, 3JPH=10.4 Hz, 2JHH=4.8 Hz, O-
CH2), 4.41 (t, H, 3JPH=10.0 Hz, 2JHH=4.8 Hz, O-CH2), 
4.21 (d, 2H, 3JPH=9.2 Hz, Py-CH2-N), 3.92 [s, 8H, O-
CH2 (DASD)], 3.83 [s, 8H, O-CH2 (DASD)], 3.16 [m, 
16H, N-CH2 (DASD)], 3.20 (m, H, Py-CH2-N-CH2), 
1.90 (m, 2H, 3JHH=4.8 Hz, 3JHH=5.2 Hz, N-CH2-CH2), 
1.66 [m, 8H, N-CH2-CH2 (DASD)], 1.55 [m, 8H, N-
CH2-CH2 (DASD)]. 13C NMR (100 MHz, CDCl3, 
ppm, in Scheme 1 the numberings of carbons were 
given): δ 173.07 (s, COO-), 157.65 (d, 3JPC=10.7 Hz, 
C1), 155.22 (s, Cf), 148.51 (s, C5), 148.10 (s, Cc), 
137.89 (s, C3), 122.63 (s, Ca), 122.43 (s, C2), 122.35 
(s, C4), 118.67 (s, Cd), 117.45 (s, Cb), 115.53 (s, Ce), 
107.33 and 107.10 [s, O-C-O (DASD)], 67.33 (d, 
2JPC=6.8 Hz, O-CH2), 52.48 (s, Py-CH2-N), 47.00 (s, 
Py-CH2-N-CH2), 64.23 and 64.14 [s, O-CH2 (DASD)], 
42.72 [s, N-CH2 (DASD)], 35.35 [s, N-CH2-CH2 
(DASD)], 26.24 (d, 3JPC=3.8 Hz, N-CH2-CH2). 
Synthesis of 2-pyridyl(N/N)spirotetrapiperidino-PMOS (7a) 
The work-up procedure was similar to that of 
compound 6a, using 5a (0.50 g, 0.77 mmol) and 
gentisic acid (0.12 g, 0.77 mmol). The reaction 
mixture was refluxed for over 45 h. After that,  
the solvent was evaporated under vacuo. A colourless 
powder of 7a was crystallized from toluene.  
Yield: 0.36 g (58%). Anal. Calcd. for P3N10O4C37H60, 
801.40 g/mol: C, 55.45; H, 7.55; N, 17.48. Found:  
C, 55.08; H, 7.69; N, 17.09. FTIR (KBr, cm−1): ν 3198 
(O-H), 2925, 2850 (C-H aliph.), 2632 (N+-H), 1591 
(asymm.), 1372 (symm.) (COO−), 1244 (asymm.), 
1159 (symm.) (P=N). 1H NMR (400 MHz, CDCl3, 
ppm, in Scheme 1 the numberings of protons were 
given): δ 8.58 (d, H, 3JHH=4.8 Hz, H5), 8.45 (b, 2H, 
Ar-OH), 7.78 (dd, H, 3JHH=8.0 Hz, 3JHH=7.6 Hz, H3), 
7.70 (d, H, 3JHH=7.6 Hz, H2), 7.52 (d, 1H, 3JHH=2.8 
Hz, Hb), 7.15 (dd, H, 3JHH=8.0 Hz, 3JHH=7.6 Hz, H4), 
6.98 (dd, 1H, 3JHH=8.8 Hz, 3JHH=3.0 Hz, Hd), 6.75  
(d, 1H, 3JHH=8.8 Hz, He), 4.30 (d, 2H, 3JPH=9.2 Hz, 
Py-CH2-N), 3.31 (m, 2H, CH3-N-CH2), 3.03 (m, 2H, 
Py-CH2-N-CH2), 3.10 [m, 8H, N-CH2 (piper)], 2.97 [m, 
8H, N-CH2 (piper)], 2.71 (d, 3H, 3JPH=12.0 Hz,  
N-CH3), 1.88 (m, 3JHH=5.2 Hz, 3JHH=5.2 Hz, 2H,  
N-CH2-CH2), 1.51 [m, 16H, N-CH2-CH2 (piper)], 1.35 
[m, 4H, N-CH2-CH2-CH2 (piper)], 1.33 [m, 4H,  
N-CH2-CH2-CH2 (piper)]. 13C NMR (100 MHz, CDCl3, 
ppm, in Scheme 1 the numberings of carbons were 
given): δ 173.47 (s, COO-), 157.85 (d, 3JPC=9.2 Hz, C1), 
155.31 (s, Cf), 149.14 (s, C5), 148.53 (s, Cc), 138.34 
(s, C3), 123.26 (s, Ca), 123.12 (s, C2), 122.24 (s, C4), 
116.19 (s, Cd), 117.63 (s, Cb), 115.19 (s, Ce), 51.53 
(m, Py-CH2-N), 50.61 (s, Py-CH2-N-CH2), 47.28  
(s, CH3-N-CH2), 45.91 and 45.75 [s, N-CH2 (piper)], 
35.69 (m, N-CH3), 25.30 (s, N-CH2-CH2), 26.31 and 
26.17 [(s, N-CH2-CH2 (piper)], 24.73 and 24.55  
[(s, N-CH2-CH2-CH2 (piper)].  
 
Evaluation of in vitro antimicrobial activity 
In the present study, the antimicrobial effects of the 
free phosphazene bases (4a-4d and 5a-5d) and 
PMOSs (6a-6d and 7a) were assessed in order to 
discover the potential antimicrobial agents against the 
selected bacteria and yeast strains. The free 
phosphazene bases (4a-4d and 5a-5d) and PMOSs 
were tested comparatively for their in vitro 
antibacterial activities against five G(+) 
{Enterococcus faecalis ATCC 29212, Enterococcus 
hirae ATCC 10541, Staphylococcus aureus ATCC 
25923, Bacillus subtilis ATCC 6633, Bacillus cereus 
INDIAN J CHEM, SEC A, APRIL 2020 
 
 
538
NRRL B-3711}, and three G(-) {Proteus vulgaris 
ATCC 8427, Salmonella typhimurium ATCC 14028, 
Klebsiella pneumaniae ATCC 13883} bacteria, and 
also for their antifungal activities against three fungi 
{Candida albicans ATCC 10231, Candida krusei 
ATCC 6258, Candida tropicalis Y-12968} using the 
agar-well diffusion method.42 Microorganisms were 
acquired from the collections of Gazi University 
Molecular Biology Culture Collection, Turkey. For 
positive control, ampicillin (10 µg/mL) and 
chloramphenicol (30 µg/mL) were selected as the 
reference antibacterial agents, and ketoconazole (50 
µg/mL) was used as reference antifungal agent. The 
susceptibility testing was performed using the 
BACTEC MGIT 960 (Becton Diskinson, Sparks, 
MD) systems. Dimethyl sulfoxide (DMSO) was used 
as the negative control since it was used as the solvent 
for all the compounds. G(-) and G(+) bacteria were 
grown on nutrient broth agar plates and incubated at 
37 °C for 24 h. Whilst, the yeast strains were grown in 
Sabouraud dextrose agar (SDA) medium and 
incubated at 30 °C for 48 h. After incubation, 
bacterial suspensions were adjusted to a turbidity of 
0.5 McFarland. SDA (for fungal strains) and Mueller 
Hinton agar (MHA) (for bacterial strains) were mixed 
with 1% culture suspension and poured into plates. A 
suspension of the tested microorganism was spread 
over the surface of agar plates (SDA and MHA). The 
testing compounds (2000 µM) were added into the 
wells. The diameter of the inhibition zone was 
measured in millimeters.  
The minimum inhibitory concentration (MIC), 
minimum bactericidal concentration (MBC) and 
minimum fungicidal concentration (MFC) values of 
the active compounds were also determined with the 
broth microdilution method.43 A preculture of bacteria 
was grown in Lysogeny broth (LB) overnight at  
37 °C. The bacteria were treated with various 
concentrations of the compounds.  
 
Determination of the DNA and compound interactions 
To evaluate the interactions between the compound 
and DNA, the agarose gel electrophoresis technique 
was performed using plasmid DNA.44 The stock 
solutions of the free phosphazene bases (4a-4d and 
5a-5d) and PMOSs (6a-6d and 7a) in DMSO were 
prepared and used within 1 h. Then, aliquots of 
decreasing concentrations of the compounds ranging 
from 2000 to 250 µM were incubated with 
supercoiled plasmid DNA in an incubator at 37 °C for 
24 h in the dark. The compound/DNA mixtures were 
loaded onto the agarose gel with a loading buffer 
(0.1% bromophenol blue, 0.1% xylene cyanol). The 
agarose gel electrophoresis was made under TAE 
buffer (0.05 M Tris base, 0.05 M glacial acetic acid 
and 1 mM EDTA, pH = 8.0) for 3 h at 60 V. After 
that, the gel was stained with ethidium bromide  
(0.5 µg/mL), visualized under UV light using a 
transilluminator (BioDoc Analyzer, Biometra) and the 
image was photographed with a video camera. Each 
experiment was repeated for three times and the mean 
values were given. 
 
HindIII and BamHI digestions of the compound-plasmid DNA 
mixture 
The affinity evaluation between the prepared 
compounds (4a-7a and 4d-6d) and guanine-guanine 
(G/G) and/or adenine-adenine (A/A) regions was 
investigated through restriction endonuclease 
analysis.45 Compound/DNA mixtures were incubated 
for 24 h, and then restricted with HindIII and BamHI 
enzymes at 37 °C. The restricted DNA was run in 
agarose gel electrophoresis for 1 h at 70 V in TAE 
buffer.44 The gel was stained with ethidium bromide 
(0.5 µg/mL), and then the gel was viewed with a 
transilluminator, and the image was photographed 
with a video-camera and saved as a TIFF file. 
BamHI enzyme binds at the sequence 5'-
G/GATCC-3' and since pBR322 plasmid DNA 
contains a single sequence of that, cleaves this 
sequence. BamHI then converts supercoiled Form I 
and open circular Form II to linear form of linear 
DNA (Form III). HindIII recognizes the sequence 5'-
A/AGCTT-3' and cleaves this sequence. As a result, 
HindIII converts Form I and Form II to Form III 
similarly to BamHI.  
 
Determination of the cytotoxic activity with WST-1 method  
The cell viability was examined using WST-1 
assay.46 Normal L929 fibroblast cells (healthy cell 
group, 5×103 cells per well) and MDA-MB-231 
(5×103 cells per well) breast cancer cells were  
placed in flasks containing Dulbecco's Modified 
Eagle's medium (DMEM) and Roswell Park 
Memorial Institute (RPMI) 1640, respectively, with  
L-glutamine, 10% FCS, and 1% antibiotic. They were 
kept in a CO2 incubator conditioned with 5% CO2 at 
37 °C for 48 h until the cells attached to the bottom of 
the plate, then the cell culture medium was replaced 
with fresh medium and different concentrations  
(100-12.5 µg/mL) of the compounds were placed  
into the wells. The cell culture medium was removed 
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and the cells were treated with trypsin-EDTA  
(0.5 mL per flask) for harvesting cells, Afterwards, 
the cells were transferred into 15 mL Eppendorf tubes 
and centrifuged at 2.500 rpm for 2 min. The cells 
were used after removing the supernatant in the 
cytotoxic activity studies. Doxorubicin was used at 
various concentrations as positive control. The plates 
containing DMEM with L-glutamine, 10% FCS, and 
1% antibiotic and RPMI with L-glutamine, 10% FCS, 
and 1% antibiotic were incubated at 37 °C in an 
incubator for 24 h. Following 24 h incubation under 
the same conditions, WST-1 (a water-soluble 
tetrazolium salt) reagent (5 µL) was added into each 
well. Upon incubation for an additional 4 h, the plates 
were immediately read in an Elisa Microplate Reader 
(BioTek, USA) at 440 nm wavelength and the 
percentage of cell viability of each group was 
calculated according to the definition of the control 
cell viability as 100%. 
 
Determination of the antituberculosis activity against 
Mycobacterium tuberculosis 
The agar proportion method was performed using 
Middlebrook 7H10 agar. This is a reference method 
for drug susceptibility testing of Mycobacterium 
tuberculosis according to CLSI recommendations.47,48 
The final concentration of each compound in the 
medium was firstly adjusted to 5, 10, 20, 40 and  
80 µg/mL, respectively. The final concentrations  
were changed for the compounds displaying 
antituberculosis activity to M. tuberculosis H37Rv 
strain, to detect minimal inhibition concentration 
(MIC) of compounds. Middlebrook 7H10 medium 
was prepared and autoclaved at 121°C for 10 minutes. 
When cooled to 55 °C, Middlebrook 7H10 medium 
was mixed with Middlebrook OADC Enrichment and 
dissolved compounds, before pouring into the Petri 
dish bottom divided into four partitions. Quality 
controls of media were done.  
 
Results and Discussion 
 
Syntheses and characterizations 
The syntheses of PMOSs (6a-6d and 7a) were 
achieved by the reactions of the corresponding free 
cyclotriphosphazene bases (4a-4d and 5a) with 
gentisic acid in dry THF (Scheme 1). These types of 
the PMOS are the first examples of pyridyl 
substituted phosphazenium salts synthesized from the 
reactions of the cyclotriphosphazene free bases and 
bulky gentisic acid. The reaction yields of the PMOS 
were calculated in the range of (58–77)%. In addition, 
all of the PMOSs (6a-6d and 7a) were slightly soluble 
in hot water, however, fairly soluble in the common 
organic apolar/polar solvents. The salts 6b and 7a 
were the waxy solids, whereas 6a, 6c and 6d were 
solid at ambient temperature. The melting points (mp) 
of 6a, 6c and 6d are 105, 139 and 119 °C, 
respectively. The crystallization of the PMOS for  
X-ray diffraction analysis was not easy, so only the 
suitable crystals of 6c were obtained. The X-ray 
crystallographic results display that 6c was protonated 
with the N atom of the cyclotriphosphazene ring  
near to the N/O spiro ring. In contrast, it was  
observed in the literature that the protonation in  
4-fluorobenzylspiro(N/O)cyclotriphosphazenes took 
place on the nitrogen atom of the phosphazene ring 
which is non-adjacent to the N/O spiro ring.28,29 The 
data obtained from the NMR spectra of the other salts 
show that all the PMOSs are likely to be protonated in 
the nitrogen atom of the phosphazene ring. 
The proposed structures of the cyclotriphosphazene 
(5a) and PMOSs (6a–6d and 7a) were evaluated 
using the ESI-MS (for 5a, in Supplementary Data, 
Fig. S1), FTIR, 1H, 13C{1H} and 31P{1H} NMR data.  
 
NMR and IR spectroscopy 
The 31P{1H} NMR results were presented in  
Table 2 together with the corresponding bases (4a–4d 
and 5a) and their gentisic acid salts (6a–6d and 7a). 
The 31P NMR data of the free bases are taken from the 
literature for comparison purposes. The spin systems 
of the PMOS were determined as AX2 (6a, 6d and 7a) 
and AB2 (6b and 6c). Since the proton can exchange 
between the N atoms of the cyclotriphosphazene ring 
in the CDCl3 solution at the ambient temperature. 
Otherwise, as expected the spin systems of the PMOS 
ought to be as ABX or AMX. The 31P NMR spectra of 
6c were also recorded at low temperatures, −28 °C, 
−20 °C, −10 °C, +10 °C and +25 °C, to confirm that 
the proton was displaced between the N atoms of the 
cyclotriphosphazene ring (Fig. 1). The spectra of 6c 
show that the spin system does not change even at 
−28 °C in the CDCl3 solution. It is deduced from this 
finding that the H+ ion displaces between the nitrogen 
atoms even at low temperatures. 
On the other hand, in all the PMOSs, the P1 
phosphorus atoms ought to be chiral centres, and they 
are expected to form a racemic mixture (R and S). 
Actually, the solid-state structure of 6c was proved 
crystallographically (see X-ray part 3.4). The space 
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group is found to be as P-1, which is amongst the 
Sohncke space groups.49,50 This compound in the solid 
state may be locked-conformation, and so it is chiral 
as it does not convert to its mirror image.49 Taking 
into account of the crystallographic check CIF report, 
6c had one chiral P center, and the absolute 
configuration of P1 center is found to be as R, 
exhibiting that there was solely single enantiomer in 
the unit cell in the solid state. But, since the proton is 
displaced between the nitrogen atoms in solution, the 
chirality disappears. It is noteworthy that this finding 
is observed for the first time in phosphazenium salts. 
The coupling constants, 2JPP, of the PMOSs (6a–6d 
and 7a) (31.6–43.7 Hz) are slightly smaller than those 
of the corresponding phosphazene bases (4a–4d and 
5a) (38.9–48.6 Hz). They are a good agreement with 
the literature values of the phosphazenium salts.28-31 
The δ P (spiro) (13.24–19.85 ppm) and δ PNN shifts 
(14.52–21.03 ppm) are smaller than those of the free 
phosphazene bases; the δ P (spiro) (19.70–23.39 ppm) 
and δ PNN shifts (18.89–22.22 ppm). As an example, 
the 31P{1H} NMR spectra of 6a and 6d were depicted 
in Fig. 2. Consequently, all these findings are 
evidence of the protonations of the free bases.  
The signals of the carbons and protons of the free 
base (5a) and PMOSs (6a–6d and 7a) were assigned 
from the 13C and 1H spectra. The 13C and 1H NMR 
spectra of the PMOS 6a were given in Supplementary 
Data, Figs S2 and S3. The obtained 13C NMR data 
were given in “Experimental Part”. The O-CH2 
carbons of the PMOS were observed in the range of 
66.92–67.80 ppm, and the average value of 2JPOC is 
7.1 Hz. The average 3JPNCC, value for the N-CH2-CH2(pyrr) 
carbons is 9.3 Hz. In addition, the carbon peaks of the 
 
Table 2 ― 31P {1H} NMR parameters of 2-pyridylspirocyclotriphosphazenes and their PMOSsa 
 
Comp. Spin Systems PNO(spiro) PNN(spiro) PNN PCl2 2JPP (Hz) 2JPP/Δν
*4 AX2 8.92 (t) - - 23.39 (d) 2JAX 38.9 -  
*5 AX2 - 11.66 (t) - 22.02 (d) 2JAX 38.9 -  
*4a AX2 20.20 (t) - 22.22 (d) - 2JAX 43.7 -  
*4b AX2 21.14 (t) - 18.89 (d) - 2JAX 43.7 -  
*4c AB2 20.05 (t) - 21.44 (d) - 2JAB 46.2 0.14  
*4d AB2 19.70 (t) - 21.30 (d) - 2JAB 48.6 0.13  
5a AX2 - 23.39 (t) 21.13 (d) - 2JAX 38.9 -  
*5b AX2 - 23.79 (t) 17.39 (d) - 2JAX 38.9 -  
*5c AX2 - 23.25 (t) 20.14 (d) - 2JAX 38.9 -  
*5d AX2  23.00 (t) 20.33 (d) - 2JAX 36.4 -  
6a AX2 13.70 (t) - 17.82 (d) - 2JAX 41.3 -  
6b AB2 15.21 (t) - 14.52 (d) - 2JAB 38.9 0.23  
6c AB2 19.85 (t) - 21.03 (d) - 2JAB 43.7 0.15  
6d AX2 16.81 (t) - 19.29 (d) - 2JAX 43.7 -  
7a AX2 - 13.24 (t) 15.98 (d) - 2JAX 31.6 -  
a242.93 MHz 31P {1H} NMR measurements in CDCl3 solutions at 298 K, and the chemical shifts referenced to external H3PO4. 
*31P {1H} NMR values of these compunds were taken from the literature references 35 and 36. 
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pyridyl ring (C1-C5) were interpreted from the 13C 
spectra of the compounds. In piperidine (6a and 7a) 
and pyrrolidine (6b) substituted PMOSs, the 3JPNCC  
 
 
values of C1 carbons of the pyridyl rings are smaller 
than those of the corresponding free phosphazene 
bases except of morpholine (6c) and DASD (6d) 
substituted ones. On the other hand, the geminal  
 
substituents of all the compounds exhibit two small 
separated peaks for N-CH2 (except 6d), N-CH2-CH2 
(except 6d), N-CH2-CH2-CH2 (for 5a, 6a and 7a),  
O-CH2 (for 6c and 6d) and O-C-O groups (for 6d), 
since two geminal groups are not equivalent to each 
other. The O-C-O and C-O-CH2 carbon signals of 6d 
were observed at 107.33; 107.10, and 64.23; 64.14 ppm, 
 
 
Fig. 1 ― 31P NMR spectra of 6c at varying temperatures (-28 °C, -20 °C, -10 °C, +10 °C and +25 °C) 
 
 
Fig. 2 ― 31P {1H} NMR spectra of the compounds 6a and 6d 
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respectively, as four separate singlets. In addition, the 
second order effect at ca. 26 ppm in the 13C spectrum 
of 6b was observed. The average 3JPNCC value was 
calculated as 8.9 Hz taking the external transitions of 
the triplets (Supplementary Data, Fig. S4). The 
similar observations were reported in the literature for 
some pyrrolidino phosphazene derivatives. The 
obtained 3JPNCC value is consistent with the literature 
data.35,36 The interpretations of the δ-shifts of COO- 
and Ca-Cf carbons of the gentisic acid ions were also 
made in the PMOS (Fig. 1), and the results were 
proved to be in compliance with the literature 
data.28,29 
The obtained 1H NMR data were presented in 
“Experimental Part”. The integral ratio in 1H spectrum 
of 5a shows that four Cl atoms were replaced by 
piperidine. The δH-shifts of all the PMOSs have 
almost the same δH values with the corresponding free 
bases.35,36 Furthermore, in the PMOS, the 3JPNCH 
values of Py-CH2-N protons are larger than those of 
the corresponding free phosphazene bases35,36. The N-
CH3 protons of the free base (5a) and PMOS (7a) 
were observed in 2.57 ppm and 2.71 ppm, 
respectively. The large 3JPNCH values were calculated 
as 13.2 Hz and 12.0 Hz from the doublets of the 
spectra of 5a and 7a, respectively. Furthermore, the  
δ-shifts and coupling constants of Hb, Hd and He 
protons of the gentisic acid ions were evaluated  
(Fig. 1), and the findings are in agreement with the 
literature data.28,29 
The characteristic FTIR bands of the free base (5a) 
and PMOSs (6a–6d and 7a) were given in 
“Experimental Part”. The sharp asymmetric and 
symmetric vibrations are observed between  
1258–1240 cm−1 and 1198-1151 cm−1, referred to the 
P=N bonds of the P3N3 rings.51,52 The ν(N+-H) stretching 
bands of the PMOSs (6a–6d and 7a) were observed in 
the range of 2675–2632 cm−1. Two strong 
characteristic bands in the ranges of 1595–1571 cm−1 
and 1379–1367 cm−1, which are determined to the 
asymmetric and symmetric vibrations of ν(COO-) bonds, 
respectively prove the PMOS formation.28,29 Besides, 
the only 2-pyridyl(N/N)spirotetrapiperidino-PMOSs 
(6a and 7a) exhibit the νO-H (ca. 3200 cm−1) absorption 
frequencies. 
The microanalytical, IR, NMR (1H, 13C, and 31P) 
and X-ray structural data (for 4a and 6c) exhibit  
that the molecular structures of the compounds  
are consistent with the proposed structures in  
Scheme 1.  
Thermal studies  
In the last decades, the thermal properties of the 
cyclotriphosphazenes and their phosphazenium salts 
(PMOS) were investigated using DSC and TG/DTA 
techniques.29-31 Generally, these methods are 
significantly helpful for the material science to 
understand the thermal stabilities and flame-retardant 
properties of the inorganic, organic and polymeric 
materials.53,54 The TG thermograms of the PMOSs 
(6a–6d and 7a) which are measured using same 
experimental conditions are shown in Supplementary 
Data, Fig. S5. Thermoanalytical data of the PMOS 
were also listed in Table 3.  
Taking into account of the TG graphs, there are 
some diversity in the thermal properties of the PMOS. 
The quantity of the total mass loss in the PMOS is 
almost the same, and the non-volatile inorganic 
phosphorus and nitrogen residues are in the range of 
7.87–11.92 weight%. In addition, all of the PMOS 
have somewhat different thermal decomposition 
routes, and consist of two (6c), three (6d and 7a) and 
four (6a and 6b) steps (Table 3). The PMOSs (except 
6c) incorporate toluene molecules with respect to the 
thermal analysis results. In the first step, toluene 
molecules are separated from the structures in the 
PMOSs (except 6a). After the separation of the 
toluene molecules, gentisic acid anions leave the 
structure (except 6a). Later, the pyridyl pendant 
armed, which forms the spiro ring and secondary 
amine precursors decompose and leave from the 
structure. Thermoanalytical data of 6a, 6b and 7a 
display that these salts decompose at lower 
temperatures than the other PMOSs (6c and 6d). 
Thermal stability (788 °C) of 7a, which has N/N spiro 
ring is lower than those of the others. 
 
X-Ray structures of 4a and 6c 
The crystal structure determinations of 4a and 6c 
were made using their X-ray crystallographic data. 
The molecular structures of these compounds along 
with the atom-numbering schemes were illustrated in 
Figs 3 and 4, respectively. The characteristic bond 
lengths and angles were presented in Table 4. The 
conformations of the cyclotriphosphazene rings of  
4a and 6c were illustrated by the torsion angles of  
the P3N3 ring bonds, showing that both of them were 
not pseudo-centrosymmetric (Supplementary Data, 
Fig. S6). In 4a and 6c, the N/O donor type ligand  
was bonded to the P atoms in spiro fashion,  
and the six-membered N3P3 phosphazene rings 
(P1/N1/P2/N2/P3/N3) are found to be almost planar 
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[Supplementary Data, Fig. S7a; the puckering 
parameters, QT,55 0.153(2) Å, 2= −161.5(9),  
2= 62.5(9) for 4a and Supplementary Data,  
Fig. S8(a); QT= 0.200(2) Å, 2= 29.1(9),  
2= 138.4(5) for 6c]. In addition, the six-membered 
spiro rings (P1/O1/C1/C2/C3/N4) of 4a and 6c, have 
chair [Fig. S7b; QT= 0.982(8) Å, 2= – 25.9(5),  
2= 118.8(2)] and twisted [Supplementary Data,  
Fig. S8(b); QT = 1.003(8) Å, 2= – 28.5(5),  
2= 123.3(2)] conformations, respectively. 
The average endocyclic P—N bond lengths of 4a 
and 6c are incidentally found to be like the same, 
 
Table 3 ― Thermoanalytical data of the PMOSs 
Comp. Melting 
points (°C) 
Stages Temperature 
ranges (°C) 
DTG(max) 
(°C) 
Mass loss (Theo.) 
Δm % 
Mass loss (Obs.)
Δm % 
Leaving groups Mass of residues 
(Obs.) Δm % 
(residual group)
6a 105 1 68–245 189 17.38 17.12 Gentisic acid anion 10.12 
  2 245–349 275 19.32 18.65 C7H8+Py (N2P2) 
  3 
4 
349–544 
544–1150 
442 
813 
17.51 
35.69 
18.27 
35.84 
CH2-N-(CH2)3+Piper. 
3Piper.+OP-NH 
 
6b a waxy solid 1 65–180 122 11.17 12.01 C7H8 7.87 
  2 180–368 267 25.60 25.03 Gentisic acid 
anion+O(CH2)3 
(NP2) 
  3 368–573 439 12.99 12.54 Py-CH2-NH  
  4 573–1150 870 41.15 42.50 4Pyrr.+NP-NH  
6c 139 1 123–530 277 45.35 45.38 Gentisic acid 
anion+O(CH2)2+ 
Py-CH2-N-(CH2)3-O 
10.30 
(NP2) 
  2 530–1150 794 45.23 44.32 3Morp.+N-
(CH2)2+NP-NH 
 
6d 119 1 92–224 189 7.64 7.87 C7H8 9.93 
  2 224–554 265 46.26 49.44 Gentisic acid anion+ 
4[O(CH2)2O]+ 
Py-CH2-N-(CH2)3-O 
(N2P2) 
  3 554–1150 954 31.07 32.76 4[C-(CH2)4-N]+P-NH  
7a a waxy solid 1 59–235 213 10.30 10.51 C7H8 11.92 
  2 235–549 304 50.17 49.73 Gentisic acid 
anion+3Piper.+ 
CH2-N-CH3 
(N3P2) 
  3 549–1150 788 27.89 27.84 Piper.+Py-CH2-NP-
(CH2)2 
 
 
 
Fig. 3 ― An ORTEP-356,57 drawing of 4a with the atom-
numbering scheme. Displacement ellipsoids are drawn at the 30%
probability level 
 
 
Fig. 4 ― An ORTEP-356,57 drawing of 6c with the atom-
numbering scheme. Displacement ellipsoids are drawn at the 30% 
probability level 
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1.593(3) Å (Table 4). The average exocyclic P–N 
bond lengths of 4a and 6c are also calculated as 
1.656(3) Å and 1.654(3) Å, respectively. They are 
longer than those of the average endocyclic P–N bond 
lengths. The average N–P–N bond angle of the free 
phosphazene base 4a is calculated as 117.25(14)°, 
which is slightly larger than that of the salt 6c 
[115.96(15)°]. Whilst, the average P–N–P bond 
angles of 4a and 6c are found to be as almost the 
same, and they are 122.01(7)° and 122.46(17)°, 
respectively. The variations of the P–N–P and N–P–N 
bond angles of these compounds are very small as 
compared to the other aminophosphazenes and 
phosphazenium salts.28-31,36 (Table 4).  
Furthermore, the hydrogen bond geometries of the 
PMOS 6c were listed in Supplementary Data, Table 
S1, and the packing diagram was also illustrated in 
Supplementary Data, Fig. S9. The intramolecular  
N—H···O hydrogen bond connects the gentisic acid 
ion to the cyclotriphosphazene ring (Fig. 4). The 
crystallographic data of the compounds 4a and 6c 
were stored with the Cambridge Crystallographic 
Data Centre, CCDC Nos 1853961 (for compound 4a) 
and 1853962 (for compound 6c).  
 
Antimicrobial activities 
The free phosphazene bases (4a–4d and 5a–5d) 
and PMOSs (6a–6d and 7a) were screened against the 
five G (+) (Table 5) and three G (−) (Table 6) bacteria 
and three fungi (Table 7) for their antimicrobial 
activities by the agar well diffusion method.58  
The antibacterial activities against B. subtilis G (+)  
of the compounds 5a and 7a are higher than those  
of ampisilin and chloramphenicol. However, the 
antibacterial activities against B. subtilis of 4a  
 
Table 4 ― The Selected bond lengths (Å) and angles (deg) for 4a and 6c 
 4a 6c  4a 6c 
P1–N1 1.571(3) 1.572(3) N1–P1–N3 118.07(15) 116.66(16) 
P1–N3 1.591(3) 1.590(3) N1–P2–N2 116.95(14) 115.72(15) 
P2–N1 1.606(3) 1.589(3) N2–P3–N3 116.73(14) 115.51(15) 
P2–N2 1.591(3) 1.610(3) N3–P1–N4 111.42(14) 110.02(14) 
P3–N3 1.599(3) 1.578(3) P1–N1–P2 122.40(17) 123.93(18) 
P3–N2 1.597(3) 1.617(3) P3–N2–P2 121.64(17) 120.55(17) 
P2–N6 1.645(3) 1.661(3) P1–N3–P3 122.01(17) 122.9(2) 
P2–N7 1.661(3) 1.649(3) O1–P1–N4 100.20(13) 102.09(13) 
P1–N4 1.666(3) 1.659(3) O1–P1–N3 108.98(13) 110.37(15) 
P1–O1 1.593(2) 1.590(2) N1–P1–O1 108.24(14) 107.46(14) 
 
Table 5 ― Antimicrobial activities of the free phosphazene bases (4a–4d and 5a–5d) and PMOSs (6a–6d and 7a) expressed as inhibition 
zones against the five G (+) bacteria (mm) 
 Enterococcus faecalis ATCC 
29212 G (+) 
Enterococcus hirae ATCC 
9790 G (+) 
Staphylococcus aureus ATCC 
25923 G (+) 
Bacillus 
subtilis 
ATCC 6633 
G(+) 
Bacillus cereus
NRRL B-3711 G 
(+) 
Am
p 
27.0 ± 0.0 9.0 ± 1.0 44.0 ± 1.0 23.0 ± 1.0 - 
C 20.0 ± 0.0 22.0 ± 1.0 24.0 ± 1.0 21.0 ± 1.0 - 
4 - - - 10.5 ± 0.5 10.0 ± 1.0 
5 - - - - - 
4b 13.0 ± 0.0 - - - 14.7 ± 0.9 
5b - - - - 13.0 ± 0.8 
4d 11.0 ± 0.0 - 13.0 ± 0.0 12.5 ± 0.5 13.7 ± 1.2 
5d 12.0 ± 0.0 - - - 15.0 ± 0.0 
4c - - - 12.5 ± 0.5 14.0 ± 1.4 
5c - - - 10.0 ± 0.0 15.0 ± 2.2 
4a - - 10.7± 0.5 20.0 ± 0.0 14.0 ± 1.2 
5a - - 15.3 ± 0.5 30.3 ± 0.5 30.7 ± 1.7 
6a - - 11.5 ± 0.5 18.7 ± 1.2 13.0 ± 0.0 
6b - - - 17.0 ± 0.8 17.3 ± 0.5 
6c - - 16.5 ± 0.5 20.3 ± 0.9 15.0 ± 0.8 
6d - - - 19.0 ± 1.6 17.0 ± 2.2 
7a - - 11.0 ± 0.0 30.0 ± 0.0 19.3 ± 1.9 
Amp: Ampicillin, C: Chloramphenicol 
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and 6a–6d are found to very close to reference 
antibiotics. Compound 5a is also very active against 
B. cereus G (+). On the other hand, the starting 
tetrachloro compounds 4 and 5 have the lowest  
 
 
antimicrobial activities against all the G (+) and G (−) 
pathogenic bacteria. When four Cl atoms were 
replaced with the secondary amines, the antimicrobial 
activities of the obtained tetraaminophosphazenes 
were observed to increase. Among all the compounds, 
the piperidino phosphazenes have the greatest 
antimicrobial activities against G (+) bacteria. 
However, when the activities of the free phosphazene 
bases (4a and 5a) and their gentisic acid salts (6a and  
7a) were compared, it was observed that the activities 
of these compounds were almost the same. The salts 
(6a, 6c, 6d and 7a) are slightly more effective than 
those of the free bases (4, 4b, 4d and 5d) against  
S. typhimurium G (−). Similarly, the piperidino salts 
(6a and 7a) among the others are the most effective 
compounds against S. typhimurium G (−). The 
compound 4c is almost as active as Ketokonazole 
against to C. albicans. The compounds 4b, 4d and 6b 
exhibit moderate antifungal activities against C. krusei. 
Minimum inhibitory concentrations (MIC), minimum 
bactericidal and minimal fungicidal concentrations 
(MBC/MFC) of the cyclotriphosphazenes were 
determined as well. MIC (Table 8) and MBC/MFC 
(Table 9) values of the tested compounds were ranged 
from 62.5 µM (4a for C. tropicalis) to 2000 µM and 
125 µM (4a for C. tropicalis) to 2000 µM. MIC and 
MBC/MFC values against K. pneumoniae of 5d, 6c 
and 7a are even higher than the MIC and MBC/MFC 
values of ampicillin and chloramphenicol. Likewise, 
the MIC and MBC/MFC values against P. vulgaris of 
5, 4c, 5a, 5b, 6c, 6d and 7a are found to be smaller 
than those of reference antibiotics. Consequently, it is 
understood that G(+) bacteria are more sensitive to 
the test samples as compared with G(−) bacteria.  
 
Table 6 ― Antimicrobial activities of the free phosphazene bases (4a–4d and 5a–5d) and PMOSs (6a–6d and 7a) expressed as  
inhibition zones against the three G (−) bacteria (mm) 
 Proteus vulgaris RSSK 96029 G (-) Salmonella typhimurium ATCC 14028 G (-) Klebsiella pneumoniae ATCC 13883 G (-)
Amp - 19.0 ± 1.0 - 
C 32.0 ± 1.0 38.0 ± 1.0 31.0 ± 1.0 
4 11.3 ± 0.5 14.0 ± 1.0 12.0 ± 0.0 
5 15 ± 2.16 - - 
4b 16.5 ± 1.5 14.0 ± 0.0 17.0 ± 0.0 
5b 18.3 ± 1.2 14.0 ± 0.0 16.5 ± 0.5 
4d 19.0 ± 0.0 14.7 ± 1.2 - 
5d - 15.0 ± 0.0 22.7 ± 4.5 
4c 15.3 ± 0.5 14.0 ± 1.0 16.0 ± 0.0 
5c 14.0 ± 1.0 - - 
4a - 14.0 ± 0.0 10.3 ± 0.9 
5a 20.3 ± 0.5 - 19.0 ± 0.0 
6a 15.5 ± 0.5 17.0 ± 0.0 19.0 ± 0.0 
6b 15.0 ± 0.0 - - 
6c 16.7 ± 2.4 16.0 ± 0.8 23.0 ± 0.8 
6d 21.7 ± 0.9 15.0 ± 0.0 20.0 ± 0.0 
7a 16.0 ± 0.0 17.3 ± 1.2 16.0 ± 1.4 
Amp: Ampicillin, C: Chloramphenicol 
 
 
Table 7 ― Antifungal activities of the free phosphazene bases 
(4a-4d and 5a-5d) and PMOSs (6a-6d and 7a) expressed as 
inhibition zones against the three fungi (mm) 
 Candida albicans  
ATCC 10231 
Candida topicalis  
NRRL-Y-12968 
Candida krusei
ATCC 6258 
Keto 11.0 ± 1.0 34.0 ± 2.0 18.0 ± 1.0 
4 - - - 
5 - - - 
4b - - 14.5 ± 0.5 
5b - - - 
4d - - 16.0 ± 0.0 
5d - 11.0 ± 0.0 11.0 ± 0.0 
4c 11.0 ± 0.0 - 12.0 ± 0.0 
5c - - 12.0 ± 0.8 
4a - 11.0 ± 0.9 - 
5a - - - 
6a - - - 
6b - 15.0 ± 0.0 14.0 ± 0.0 
6c - - - 
6d - - - 
7a - - - 
Keto: Ketokanozol 
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On the other hand, the pyrrolidino- and piperidino- 
cyclotriphosphazenes carrying 4-fluoro-benzyl-N/N59 
and ferrocenyl-N/N-spirocyclic groups60 were  
found to be active against E. coli, S. aureus, B. cereus  
 
 
and B. subtilis bacteria, and C. albicans and  
C. tropicalis fungi. Whereas, tetra-morpholino and 
1,4-dioxa-8-azaspiro[4,5]deca-4-fluoro-benzyl-N/N-
cyclotriphosphazene derivatives did not have a 
significant effect on these bacteria.12 However, 
analogous compounds; pyrrolidino-, piperidino-, 
morpholino and 1,4-dioxa-8-azaspiro[4,5]deca- 4-
fluoro-benzyl-N/O-spiro-cyclic cyclotriphosphazenes 
were found to be significantly active against  
C. Albicans.10 In fact, these compounds can be 
 
considered as anticandidal agents. It is reported that 
although the antifungal activities of the salts (PMOSs) 
of these compounds decrease against C. albicans, the 
antimicrobial activities against E. fecalis and E. coli 
increase.29 As a result, the antimicrobial activities of 
the aminocyclotriphosphazenes and phosphazenium 
 
Table 8. ― Minimum inhibitory concentrations (MIC, µM) of the compounds against test strains 
 Salmonellatyp
himurium 
ATCC  
14028 G (−) 
Proteus vulgaris 
RSKK  
9690 G (−) 
Staphylococcus 
aureus 
ATCC  
25923 G (+) 
Bacillus subtilis 
ATCC  
6633 G (+) 
Bacillus cereus 
NRRL  
B-3711 G (+) 
Klebsiella  
pneumoniae 
ATCC  
13883 G (−) 
Candidatropicalis
NRRL  
Y-12968 
Amp ˂19.5 1250 ˂19.5 ˂19.5 156 1250  
C 156 1250 156 78 156 625  
Keto       78 
5  125      
5b  125      
5d     2000 250  
4c  250      
5c     2000   
4a   250 2000 2000  62.5 
5a  125 250 2000 2000   
6a    2000    
6b    2000 2000   
6c 250 125  2000 2000 500  
6d  125  2000 2000   
7a 250 125  2000 2000 250  
Amp: Ampicillin, C: Chloramphenicol, Keto: Ketokanozol 
 
Table 9 ― Minimum bactericidal and minimal fungicidal concentration (MBC/MFC, µM) of the compounds against test strains 
 Salmonellaty
phimurium 
ATCC 
14028 G (−) 
Proteus  
vulgaris 
RSKK  
9690 G (−) 
Staphylococcus 
aureus 
ATCC  
25923 G (+) 
Bacillus  
subtilis 
ATCC  
6633 G (+) 
Bacillus cereus
NRRL  
B-3711 G (+) 
Klebsiella 
pneumoniae 
ATCC  
13883 G (−) 
Candidatropicalis
NRRL  
Y-12968 
Amp ˂19.5 2500  ˂19.5 ˂19.5 2500 1250  
C 1250 2500 2500 78 1250 2500  
Keto       1250 
5  250      
5b  250      
5d     2000 500  
4c  500      
5c     2000   
4a   500 2000 2000  125 
5a  250 500 2000 2000   
6a    2000    
6b    2000 2000   
6c 500 250  2000 2000 500  
6d  250  2000 2000   
7a 500 250  2000 2000 500  
Amp: Ampicillin, C: Chloramphenicol, Keto: Ketokanozol 
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salts appear to be largely dependent on the 
occurrences of the hydrogen bonds with the ligands 
attached to the phosphorus atoms and the active 
centres of microorganism cell components. 
 
Interaction with plasmid DNA and restriction enzyme 
digestion 
Interactions with plasmid DNA at four different 
concentrations of 2000, 1000, 500 and 250 μM 
according to the decreasing concentrations of the 
compounds prepared in 2000 μM concentrations 
dissolved in DMF (dimethylformamide) were 
elucidated (Fig. 5). The cleavage studies of 
supercoiled plasmid DNA were carried out using 
agarose gel electrophoresis. After binding of the 
cyclotriphosphazenes to plasmid DNA at different 
molar ratios, the changes in electrophoretic mobilities 
of the open circular (oc, relaxed) and closed circular 
(cc, supercoiled) forms were analyzed (Fig. 5).  
In general, two DNA bands; Forms I (strong) and II 
(weak), appeared in both untreated and treated 
plasmid DNA. When the concentration of the 
cyclotriphosphazenes increases, the mobilities of 
Forms I and II plasmid DNA decreases in the case of 
4 and 5. All three forms were observed for 4 and 5 as 
a result of a 24 h incubation. In the case of 4b and 5b, 
the mobilities of Forms I and II decrease. In the case 
of 5c, a coalesced band was observed in Lanes 1 and 
2. In the case of the other compounds, no changes in 
the mobilities of Forms I and II DNA bands were 
observed. The changes in the mobilities of the bands 
display changes in DNA conformations by covalent 
binding of the compounds with the DNA.  
 
BamHI and HindIII digestions of the compounds-plasmid 
DNA mixture 
To understand more about changes in DNA 
conformation, compound-DNA incubation monitored 
by BamHI and HindIII digestions were used. The 
electrophoretogram corresponding to the BamHI and 
HindIII digested incubated mixtures of pBR322 
plasmid DNA, and the free phosphazene bases (4a-4d 
and 5a-5d) and PMOSs (6a-6d and 7a) are shown in 
Fig. 6. These compounds inhibited restriction enzyme 
digestion. Untreated pBR322 plasmid DNA is applied 
to Lane P. Lane P/B and Lane P/H are placed to 
plasmid DNA digested with BamHI and HindIII, 
respectively. BamHI enzyme binds at the sequence  
5'-G/GATCC-3' and since pBR322 plasmid DNA 
contains a single sequence of that, cleaves this 
sequence. BamHI then converts supercoiled Form I 
and open circular Form II to linear form of linear 
DNA (Form III). HindIII recognizes the sequence  
5'-A/AGCTT-3' and cleaves this sequence. So, HindIII 
converts Forms I and II to Form III similarly to 
BamHI. As a result, the treatment of the compounds 
with the HindIII enzyme only the compound 5c was 
not cleaved. That is, 5c binds to the DNA through the 
5'A/AGCTT-3 ' nucleotide sequence. 
 
 
Fig. 5 ― Modification of gel electrophoretic mobility of plasmid
DNA when incubated with various concentrations of the
compounds. Concentrations are as follows: (P) untreated plasmid
DNA; for compounds: (line 1) 2000; (line 2) 1000; (line 3) 500
and (line 4) 250 μM. The top and the bottom bands correspond to
form II (open circular) and form I (covalently closed circular)
plasmids, respectively 
 
Fig. 6 ― Electrophoretograms applying to incubated mixtures of 
plasmid DNA and the compounds followed by digestion with 
BamHI and HindIII. Lane P corresponds to the untreated and 
indigested plasmid DNA. Lane B and Lane H apply to untreated 
but digestion with BamHI and HindIII, respectively 
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Cytotoxicity of the compounds on L929 fibroblast and MDA-
MB-231 breast cancer cells 
The cytotoxic activities of the PMOSs (6a, 6b and 
6d) were evaluated using WST-1 assay against L929 
healthy fibroblasts (mouse cells) and MDA-MB-231 
breast cancer cell lines. The percentages of viable 
cells were figured out at various concentrations  
(12.5–100 µg/mL) against % cell viability (Tables 10 
and 11). In terms of WST-1 results, the highest 
cytotoxic effect is observed for 6b at the lowest 
concentration (12.5 μg/mL) against fibroblast cell 
line. Whilst, the compounds 6a and 6d in the same 
experimental condition have slightly and moderately 
cytotoxic effect on the L929 fibroblast cell line, 
respectively. The highest cytotoxic effect is found to 
be for the tetrapiperidino salt 6a against to the MDA-
MB-231 breast cancer cell line, and while the 
moderate effect is observed for the tetraDASD 
substituted salt 6d.  
Consequently, the compound 6a exhibited strong 
anticancer activity against MDA-MB-231 breast 
cancer cells. IC50 values of 6a for L929 fibroblast 
and MDA-MB-231 cells were lower than 100 μg/mL. 
The anticancer activity of 6a was as effective as 
anticancer activity of doxorubicin on the MDA-MB-
231 breast cancer cell line. However, due to the 
lowest toxic activity of this compound against 
fibroblast cell as well, indicating that it may be  
a promising the anticancer drug candidate for in vivo 
experiments on account of its selective feature. On the 
other hand, the tetra-chloro/piperidino-4-fluoro-
benzyl-N/O,10 and the tetramorpholino-4-fluoro-
benzyl-N/N12 phosphazenes were referred to  
have cytotoxic activities against MCF-7 breast  
and Hela cancer cell lines, respectively. Besides,  
the tetra-pyrrolidino/piperidino-4-fluoro-benzyl-N/N 
phosphazenium salts also exhibit anticancer activities 
against DLD-1 colon cancer cells.30 
 
Antituberculosis activity 
In vitro antituberculosis activities of the free 
phosphazene bases (4a-4d and 5a-5d) and PMOSs  
(6a-6d and 7a) were evaluated against M. tuberculosis 
H37Rv reference strain using the agar proportion 
method (CLSI).47,48 After 21 days incubation, the 
susceptibility results of the cyclotriphosphazenes 
displayed that the tested compounds did not exhibit any 
activities against M. tuberculosis H37Rv strain. 
 
Conclusions 
In conclusion, the preparations of the new gentisic 
acid PMOSs containing 2-pyridyl pendant arm  
(6a-6d and 7a) were presented and whose structures 
were evaluated by various spectroscopic and 
crystallographic techniques, and scrutinized for their 
biological activities in cultured cell lines. The X-ray 
crystallographic results exhibit that 6c is protonated 
with the N of the phosphazene ring near to the N/O 
spiro ring. This compound has chirality, and the 
absolute configuration of P1 center is found to be as R 
in the solid state. But, in the CDCl3 solution, the 
proton is replaced between the nitrogen atoms, and so 
the chirality disappeared. It is noteworthy that this 
result is observed in the phosphazenium salts for the 
first time. According to these findings, all the PMOSs 
ought to have chiralities in the solid state. The  
[[Table 10 ― % Viability of the L929 fibroblast cancer cells exposed to concentrations of 12.5-100 µg/mL of the compounds for 24 h 
by WST Assay. The cell viability (%) based on mean absorbance values at 440 nm is presented (Data are expressed as a  
mean ± standard error as calculated from 3 separate experiments) 
 6d 6b 6a Doxorubicin* 
100 µg/mL 117.5 89.2 82.5 39.2 
50 µg/mL 115.5 134 123.4 40.8 
25 µg/mL 122.6 113.1 154.1 51.1 
12.5 µg/mL 119.6 95.4 171.5 57.7 
*Cell viability of the control group (an only medium) is 100% for L929 fibroblast cells 
 
Table 11 ― % Viability of MDA-MB-231 breast cancer cells exposed to concentrations of 12.5-100 µg/mL of the compounds for 24 h 
by WST Assay. The cell viability (%) based on mean absorbance values at 440 nm is presented (data are expressed as a  
mean ± standard error as calculated from 3 separate experiments) 
 6d 6b 6a Doxorubicin* 
100 µg/mL 66.85 78.60 51.54 24.62 
50 µg/mL 72.48 81.17 67.95 39.94 
25 µg/mL 77.62 80.44 66.60 42.54 
12.5 µg/mL 80.07 82.03 71.25 45.10 
*Cell viability of the control group (an only medium) is 100% for MDA-MB-231 breast cancer cell lines 
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characteristic 31P NMR spectrum of 6c was recorded 
in the range of (−28) – (+25) °C, and no changes were 
observed in AB2 spin system. Taking into account of 
this finding, one can say that the other PMOSs (6a-6d 
and 7a) may also have chiral properties in the solid 
state, but not in CDCl3 solution. The spectrum of 6c is 
used as a guide to assign the 31P NMR spectra of the 
other PMOSs. On the other hand, the thermal analysis 
results indicate that 6a, 6b and 7a decompose at lower 
temperatures than the other PMOSs (6c and 6d), and 
thermal stability (788 °C) of 7a, which has an N/N 
spiro ring is lower than those of the others. Besides, 
PMOS 6c can be used as an ionic liquid according to 
the thermoanalytical data. In addition, the 
antimicrobial activity results show that the piperidino 
phosphazenes have the greatest antimicrobial 
activities against G (+) bacteria. According to the 
cytotoxicity results, PMOS 6a has strong anticancer 
activity against MDA-MB-231 breast cancer cells 
compared to the other phosphazenium salts. However, 
since this salt exhibits very low toxicity against the 
healthy fibroblast cells, further studies ought to be 
made to use it as an anticancer drug candidate in  
in vivo experiments. 
 
Supplementary Data 
Listings of The ESI-MS spectrum of 5a (Fig. S1), 
the 13C and 1H NMR spectra of 6a (Figs. S2 and S3), 
the second order effect in 13C {1H} NMR spectrum  
of 6b (Fig. S4), TG curves of the phosphazenium salts 
(6a-6d and 7a) (Fig. S5), the shapes of the trimeric 
phosphazene rings in 4a and 6c with torsion angles 
(deg) given (Fig. S6), the conformations of (a) the 
trimeric phosphazene ring and (b) the six-membered 
spiro-ring of 4a (Fig. S7), the conformations of (a) the 
trimeric phosphazene ring and (b) the six-membered 
spiro-ring of 6c (Fig. S8), hydrogen-bond geometries 
for 6c (Table S1) and the packing diagram of 6c  
(Fig. S9). Supplementary data is available in the 
electronic form at http://www.niscair.res.in/jinfo/ijca/ 
IJCA_56A(04)533-550_SupplData.pdf. 
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